Goserelin Cannot Improve the Weakness of a Patient with Kennedy Disease after 40-Week AdministrationSHI, Zhi-Guang; JIANG, De-Ke; MEI ZHAO et al.CNS neuroscience & therapeutics (Print). 2012, Vol 18, Num 12, pp 1021-1023, issn 1755-5930, 3 p.Article

Goserelin can inhibit ovarian cancer proliferation and simultaneously protect ovarian function from cisplatin: an in vitro and in vivo studyYINGZHANG; JING XIN DING; XIANGTAO et al.Journal of chemotherapy (Testo stampato). 2013, Vol 25, Num 2, pp 96-103, issn 1120-009X, 8 p.Article

Protocole GETUG/AFU 16 : Radiothérapie du cancer de la prostate localiséCARRIE, Christian.Correspondances en onco-urologie. 2012, Vol 3, Num 4, pp 152-155, issn 2110-087X, 4 p.Article

Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of goserelin in rabbit plasmaMIN KYUNG KIM; TAE HO LEE; YOUM, Jeong-Rok et al.Journal of chromatography. B. 2010, Vol 878, Num 24, pp 2235-2242, issn 1570-0232, 8 p.Article

Genic expression of the uterine leiomyoma in reproductive-aged women after treatment with goserelinBORSARI, Rodrigo; BOZZINI, Nilo; RODRIGUES JUNQUEIRA, Consuelo et al.Fertility and sterility. 2010, Vol 94, Num 3, pp 1072-1077, issn 0015-0282, 6 p.Article

Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast CancerHACKSHAW, Allan; BAUM, Michael; VALENTINI, Miriam et al.Journal of the National Cancer Institute. 2009, Vol 101, Num 5, pp 341-349, issn 0027-8874, 9 p.Article

L'hormonothérapie du cancer du sein : la fin du tamoxifène ? = Hormone therapy in breast cancer: the end of tamoxifen?DELOZIER, Thierry.Bulletin du cancer. 2005, Vol 92, Num 2, pp 142-150, issn 0007-4551, 9 p.Article

The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trialSOYSAL, Seyide; SOYSAL, Mehmet Emin; OZER, Suzan et al.Human reproduction (Oxford. Print). 2004, Vol 19, Num 1, pp 160-167, issn 0268-1161, 8 p.Article

Acute goserelin administration inhibits gonadotropin and androgen secretion in post-menopausal women with ovarian hyperandrogenismDI BISCEGLIE, C; BROCATO, L; TAGLIABUE, M et al.Journal of endocrinological investigation (Testo stampato). 2003, Vol 26, Num 3, pp 206-210, issn 0391-4097, 5 p.Article

Overtreatment of a patient with presumed recurrent prostate cancer based on false-positive prostate specific antigen resultsLEIBOWITZ, Stacey B; OH, William K.The Journal of urology. 2003, Vol 170, Num 4, issn 0022-5347, p. 1305, 1Article

Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal Patients with node-positive, Early breast cancer: The zoladex Early breast cancer research association trialists groupDE HAES, H; OLSCHEWSKI, M; KAUFMANN, M et al.Journal of clinical oncology. 2003, Vol 21, Num 24, pp 4510-4516, issn 0732-183X, 7 p.Article

Survival analyses from the ZEBRA study: goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancerKAUFMANN, M; JONAT, W; BLAMEY, R et al.European journal of cancer (1990). 2003, Vol 39, Num 12, pp 1711-1717, issn 0959-8049, 7 p.Article

Side effects of adjuvant endocrine treatment in Premenopausal breast cancer patients: A prospective randomized studyNYSTEDT, Marianne; BERGLUND, Gunilla; BOLUND, Christina et al.Journal of clinical oncology. 2003, Vol 21, Num 9, pp 1836-1844, issn 0732-183X, 9 p.Article

Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patientsPEREZ-TENORIO, G; STAL, O.British journal of cancer. 2002, Vol 86, Num 4, pp 540-545, issn 0007-0920Article

Adjuvant endocrine treatment (goserelin vs tamoxifen) in pre-menopausal patients with operable node positive stage II breast cancer. A prospective randomized national multicenter studySÖREIDE, J. A; VARHAUG, J. E; FJÖSNE, H. E et al.European journal of surgical oncology. 2002, Vol 28, Num 5, pp 505-510, issn 0748-7983Article

Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association studyJONAT, W; KAUFMANN, M; EIERMANN, W et al.Journal of clinical oncology. 2002, Vol 20, Num 24, pp 4628-4635, issn 0732-183X, 8 p.Article

FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablationOYAMA, N; AKINO, H; SUZUKI, Y et al.Nuclear medicine communications. 2001, Vol 22, Num 9, pp 963-969, issn 0143-3636Article

Goserelin (Zoladex®) or Orchiectomy in metastatic prostate cancer? A quality of life and cost-effectiveness analysisNYGARD, R; NORUM, J; DUE, J et al.Anticancer research. 2001, Vol 21, Num 1B, pp 781-788, issn 0250-7005Article

The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancer. Commentary. Authors' replyTOMERA, Kevin; GLEASON, Donald; MCLEOD, D et al.The Journal of urology. 2001, Vol 165, Num 5, pp 1585-1589, issn 0022-5347Article

Traitement hormonal du cancer du sein métastasé chez la femme non ménopausée = Hormonal treatment of metastatic breast cancer in premenopausal womenLa Revue Prescrire. 1999, Vol 19, Num 192, issn 0247-7750, p. 96Article

Vorozole results in greater oestrogen suppression than formestane in postmenopausal women and when added to goserelin in premenopausal women with advanced breast cancerDOWSETT, M; DOODY, D; MIALL, S et al.Breast cancer research and treatment. 1999, Vol 56, Num 1, pp 25-34, issn 0167-6806Article

Combined surgical and medical approach to intravenous leiomyomatosis with cardiac extensionHAMELEERS, J. A; ZEEBREGTS, C. J. A. M; HAMERLIJNCK, R. P. H. M et al.Acta chirurgica Belgica. 1999, Num 2, pp 92-94, issn 0001-5458Article

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancerMESSING, E. M; MANOLA, J; SAROSDY, M et al.The New England journal of medicine. 1999, Vol 341, Num 24, pp 1781-1788, issn 0028-4793Article

Comparison of goserelin and leuprolide in combined androgen blockade therapySAROSDY, M. F; SCHELLHAMMER, P. F; SCHELLENGER, J. J et al.Urology (Ridgewood, NJ). 1998, Vol 52, Num 1, pp 82-88, issn 0090-4295Article

Goserelin acetate (Zoladex)^* with or without hormone replacement therapy for the treatment of endometriosisMOGHISSI, K. S; SCHLAFF, W. D; OLIVE, D. L et al.Fertility and sterility. 1998, Vol 69, Num 6, pp 1056-1062, issn 0015-0282Article